Tuesday, December 22, 2009

Bulls agree to trade Hinrich to Wiz

The Chicago Bulls agreed to trade veteran guard Kirk Hinrich and the 17th pick in the draft to the Washington Wizards on Thursday, freeing up more salary-cap space, a person familiar with the situation said.
The Bulls will receive a future second-round pick in the deal, which gives them enough room to go after two high-profile free agents.
he Bulls have an all-star point guard in Derrick Rose and are looking for more after back-to-back 41-win seasons that ended with first-round playoff losses. They fired coach Vinny Del Negro and replaced him with longtime NBA assistant Tom Thibodeau, the mastermind behind a dominant defence that helped Boston reach the NBA finals two of the past three years.
The longest tenured active Bulls player, Hinrich has averaged 13.4 points in seven seasons and was John Paxson's first draft pick as general manager in 2003.

Friday, December 11, 2009

Patriots Need to Concentrate on Running Game in 2010

Bill Belichick as the head coach, the Patriots have always been a team about matchups. On both sides of the ball, they always manage to adapt their game plan in the attempt to exploit their opponent's weaknesses.
The NFL is a passing league, and any team with Tom Brady should be a passing team. But New England's passing attack was inconsistent in 2009, and the team actually performed better when there was a conscious decision to keep the ball in the hands of its five running backs.
The Patriots were 3-0 last season when they had more rush attempts than pass attempts (including sacks), and all three of those games came from Weeks 14-16, when the weather deteriorated and the Pats were forced to rely on the run.
Tom Brady be better in the fourth quarter

Tuesday, December 08, 2009

Vitamin D Reduces Risk of Multiple Sclerosis

Supplements and Vitamins numerous studies of MS have shown a correlation between disease frequency and geographic location, with the general rule being that as a person gets further away from the equator, their MS risk rises. This has often been reduced to sun exposure, with one of the more obvious implications being that sunlight causes the body to create Vitamin D and therefore Vitamin D just might have a protective affect against MS.

A new study released yesterday provides compelling statistics behind that claim, saying in short that Vitamin D seems to reduce the risk of developing MS in Caucasians.. While the study does not make any claims about people who already have MS benefiting from Vitamin D supplementation.

Tuesday, December 01, 2009

MS Walking Improvement Drug Gets FDA Help

Fampridine-SRMost of the MS therapies in the drug development pipeline, or even available today, are targeted at reducing relapses and decreasing disability progression.

It makes Acorda Therapeutics Fampridine-SR quite interesting. In Phase III trials, it is targeted specifically at one particularly onerous aspect of the MS burden impact on walking ability.

Acorda and the United States Food and Drug Administration recently reached an agreement on a pathway to getting Fampridine approved for this indication. In addition to a Phase III trial currently underway, Acorda will work with the FDA''s Special Protocol Assessment to ensure their trial design proves that individuals treated with Fampridine-SR are significantly more likely to have consistent improvements in their walking than those treated with placebo...